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GUEST EDITORIAL 
The Future of Psychiatric Genetics 
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The core aim of psychiatric genetics is 
the dissection of the genetic etiology of 
specific psychiatric disorders, with a view to 
understanding pathogenesis. Identification 
of individuals at risk and rationalization of 
treatment ate secondary goals. Pioneering 
family, twin and adoption studies in the last 
century paved the way for these lofty goals 
by establishing a heritable etiology for several 
severe psychiatric disorders (McGuffin et al. 
1994). 
Recent advances in genomics have pro-
vided the tools needed to tackle these goals. 
The draft human genome sequence is 
complete, and international collaborations 
have assured rapid annotation of the ge-
nomic sequences (Sachidanandam et al., 
2001). We are well on our way to 
identification of most of the variations that 
occur in the human genome. High through-
put genotyping technologies are evolving 
rapidly and will enable accurate, economic 
methods for analysis of genomic variations 
in large samples (Kwok, 2001). These 
resources complement the classical gene 
mapping approaches that have been used 
successfully to identify genes for several 
thousand hereditary diseases (Collins, 1992). 
The typical mapping process initially involves 
identification of large chromosomal segments 
shared among affected members of pedigrees 
(linkage analysis), followed by 'fine mapping', 
of localization of the disease gene in the 
linked region by comparison of cases and 
appropriate controls 'association analysis'. 
Based on these evolving genomic re-
sources, success in mapping genes for 
psychiatric disorders was predicted two 
decades ago (Gurling, 1985). Indeed, there 
have been significant strides in gene mapping 
efforts. For example, genetic variants that 
may confer risk for common (in disorders 
such as schizophrenia and bipolar disorder 
have been identified and the results repli-
cated (Harrison & Owen, 2003). However, 
the typical risk conferred by such variants 
is relatively small (odds ratios of 2 or less). 
The clinical relevance of such results can 
therefore be questioned. The promise of 
linkage analysis has not been fulfilled 
completely (Moldin, 1997; Grottesman & 
Moldin, 1997). Though some consistent 
linkage results are available, the linked regions 
are typically extensive (several centiMorgans 
or millions of bases) (Levinson et al., 2000); 
(Lewis et al., 2003); (Segurado et al., 2003). 
Here, we identify the possible reasons for 
the inconsistencies and unfulfilled promises. 
We also suggest plausible routes to future 
success in mapping efforts. 
Along with other common multi-factorial 
diseases such as diabetes and hypertension, 
the etiological dissection of psychiatric 
disorders poses a difficult problem: though 
a significant heritability is well established, 
the number of loci contributing to the 
heritable risk is unknown a Priori. If, as 
seems likely from current efforts, the risk 
conferred by individual loci is relatively 
small, thousands of participants may be 
required flit consistent identification (Moldin, 
1997). This problem is compounded by our 
relative ignorance abosir environmental (non-
genetic) risk factors (Moldin & Gortesman, 
1997). Hence it is difficult to test inter-
actions between risk factors. In addition the 
available mapping tools, which rely heavily 
on recombination, are more suitable for 
heritable diseases for which variation in only 
one gene provides most of the risk (Risch, 
2000). Compounded by our relative ignorance 
about the pathogenesis of most of these 
disorders, it is easy to understand why is 
has been difficult to identify genes that 
confer only a small proportion of the 
overall risk (Risch, 2000). 
Is there a solution for these seemingly 
intractable problems? We suggest that linkage 
studies should nor be abandoned, because 
such approaches continue to bear fruit. For 
example, a susceptibility gene for Crohn's 
disease was recently identified thus (Rioux 
et al., 2001). Given the aforementioned 
difficulties, it would be preferable to confine 
the linkage approach to subgroups or traits 
that clearly provide evidence for Mendclian 
inheritance (Terwilliger & Goring, 2000; 
Weiss & Terwihiger, 2000). Such scenarios 
mav be present in rare families or genetically 
isolated pedigrees. Nevertheless, they merit 
investigation. linkage analysis of quantitative 
traits using variance component based 
approaches have proved successful for 
common (non-pathological) traits; such 
approaches also deserve evaluation for 
common human diseases, provided 
adequately powered samples are available 
(Almasy & Blangero, 1998). 
At the same time, alternatives to the 
classical linkage based mapping approaches 
should also be invested in. Recent contro-
versies regarding candidate gene association 
studies should be revisited (Nimgaonkar, 
1997). Such approaches have been criticized 
in the past because of the low prior 
probability of detecting associations said 
because of inadequate attention to com-
plexities in the genetics of outbred 
populations typically used for association 
analyses (Weiss & Terwilliger, 2000). 
Notwithstanding such difficulties, we be-
lieve that there continues to be a place for 
association studies in the geneticist's toolbox. 
We suggest that this approach be reserved 
for positional candidates: genes localized to 
linked regions and which encode proteins 
with a persuasive rule in pathogenesis. Due 
recognition of the prior probability for 
association is also merited. Arguably, the 
well replicated association between apoK4 
and late inset Alzheimer's disease is the best 
example ot this approach. We have recently 
identified association between schizophrenia 
and polymorphisms of the Regulator of G. 
Protein Signaling (RG.S4) using this approach 
(Chowdari et al 2002). KG 54 is localized to 
chromosome lq22, a region with prior 
reports of linkage (Brzustowiez, et al 2000). 
RGS4 is also an interesting candidate gene 
as it was identified following expression 
analysis of post-mortem brain tissue (Mimics, 
et al 2001). With further refinement, agnostic 
methods such as expression analyses arc 
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likely to be particularly useful for identifying 
candidate genes are likely to lie particularly 
useful for disorders of unknown 
parhogeisesis. 
Co—morbidity of the disorder of interest 
with chromosomal abnormalities, such as 
deletions and unbalanced translocations also 
need to be pursued aggressively. Such 
'accidents of nature' may prove valuable 
reagents for mapping efforts, if it is possible 
to conclusively identify the gene/s disrupted 
in the proband. This approach recendy 
enabled the identification of DISCI as a 
susceptibility gene for schizophrenia (Devon 
et al., 2001). 
How can researchers in India contribute 
to gene mapping efforts? India is a highly 
desirable venue for such efforts, because of 
the availability of large, cooperative, intact 
and stable families. Genetically isolated 
populations with particularly desirable 
characteristics for mapping efforts may also 
be present, but have not been investigated. 
An equally important asset is the availability 
of highly skilled clinical and genetic expertise. 
The clinical expertise is especially valued, 
because errors in diagnosis can contribute 
inordinately to major inconsistencies in 
mapping efforts. On the other hand, an 
observant clinician who identifies a patient 
with a cyrogenetic abnormality may well 
provide the key to solving the puzzling 
etiology of heritable psychiatric disorders. 
Vith adequate support from research foul-
ig agencies, Indian efforts may open up 
. -w vistas in psychiatric genetic research. 
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